<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">ACM</journal-id><journal-title-group><journal-title>Advances in Clinical Medicine</journal-title></journal-title-group><issn pub-type="epub">2161-8712</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.12677/ACM.2021.115342</article-id><article-id pub-id-type="publisher-id">ACM-42751</article-id><article-categories><subj-group subj-group-type="heading"><subject>ACM20210500000_63525286.pdf</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>医药卫生</subject></subj-group></article-categories><title-group><article-title>
 
 
  PDGF促进骨折愈合的研究进展
  Research Progress of PDGF in Promoting Fracture Healing
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>王</surname><given-names>亚楠</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>曹</surname><given-names>志强</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff3"><addr-line>青海大学附属医院，青海 西宁</addr-line></aff><aff id="aff2"><addr-line>青海大学研究生院，青海 西宁</addr-line></aff><aff id="aff1"><addr-line>null</addr-line></aff><pub-date pub-type="epub"><day>08</day><month>05</month><year>2021</year></pub-date><volume>11</volume><issue>05</issue><fpage>2381</fpage><lpage>2386</lpage><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  骨折的愈合问题是骨科医师长久以来关心的问题，骨折愈合是骨组织完全性再生的过程，各种细胞因子在不同的骨折愈合阶段发挥不同的作用；随着外科技术的不断成熟与完善，目前仍有约10%的骨折病人存在骨折不愈合或延迟愈合的情况。近年来，有相关研究表明，血小板衍生生长因子(PDGF)对于骨折不愈合或延迟愈合病人有着良好的促进骨折愈合作用。PDGF作为一种有效的有丝分裂原，对包括成骨系细胞在内的多种间充质细胞有刺激作用。对于PDGF的进一步研究，能够对临床骨折患者提供新的更优的选择。本文就PDGF促进骨折愈合机制以及研究进展作一综述。
   Fracture healing is a process of complete regeneration of bone tissue. Various cytokines play different roles in different stages of fracture healing. With the continuous maturity and improvement of surgical technology, about 10% of fracture patients still have nonunion or delayed union. In recent years, related studies have shown that platelet-derived growth factor (PDGF) has a good effect on promoting fracture healing in patients with nonunion or delayed union. As an effective mitogen, PDGF can stimulate a variety of mesenchymal cells including osteoblasts. The further study of PDGF can provide a new and better choice for clinical fracture patients. This article reviews the mechanism and research progress of PDGF in promoting fracture healing.
 
</p></abstract><kwd-group><kwd>PDGF，骨折愈合, PDGF</kwd><kwd> Fracture Healing</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>摘要</title><p>骨折的愈合问题是骨科医师长久以来关心的问题，骨折愈合是骨组织完全性再生的过程，各种细胞因子在不同的骨折愈合阶段发挥不同的作用；随着外科技术的不断成熟与完善，目前仍有约10%的骨折病人存在骨折不愈合或延迟愈合的情况。近年来，有相关研究表明，血小板衍生生长因子(PDGF)对于骨折不愈合或延迟愈合病人有着良好的促进骨折愈合作用。PDGF作为一种有效的有丝分裂原，对包括成骨系细胞在内的多种间充质细胞有刺激作用。对于PDGF的进一步研究，能够对临床骨折患者提供新的更优的选择。本文就PDGF促进骨折愈合机制以及研究进展作一综述。</p></sec><sec id="s2"><title>关键词</title><p>PDGF，骨折愈合</p></sec><sec id="s3"><title>Research Progress of PDGF in Promoting Fracture Healing</title><p>Yanan Wang<sup>1</sup>, Zhiqiang Cao<sup>2*</sup></p><p><sup>1</sup>Graduate School of Qinghai University, Xining Qinghai</p><p><sup>2</sup>Qinghai University Affiliated Hospital, Xining Qinghai</p><p><img src="//html.hanspub.org/file/51-1572265x5_hanspub.png" /></p><p>Received: Apr. 25<sup>th</sup>, 2021; accepted: May 8<sup>th</sup>, 2021; published: May 28<sup>th</sup>, 2021</p><p><img src="//html.hanspub.org/file/51-1572265x6_hanspub.png" /></p></sec><sec id="s4"><title>ABSTRACT</title><p>Fracture healing is a process of complete regeneration of bone tissue. Various cytokines play different roles in different stages of fracture healing. With the continuous maturity and improvement of surgical technology, about 10% of fracture patients still have nonunion or delayed union. In recent years, related studies have shown that platelet-derived growth factor (PDGF) has a good effect on promoting fracture healing in patients with nonunion or delayed union. As an effective mitogen, PDGF can stimulate a variety of mesenchymal cells including osteoblasts. The further study of PDGF can provide a new and better choice for clinical fracture patients. This article reviews the mechanism and research progress of PDGF in promoting fracture healing.</p><p>Keywords:PDGF, Fracture Healing</p><disp-formula id="hanspub.42751-formula52"><graphic xlink:href="//html.hanspub.org/file/51-1572265x7_hanspub.png"  xlink:type="simple"/></disp-formula><p>Copyright &#169; 2021 by author(s) and Hans Publishers Inc.</p><p>This work is licensed under the Creative Commons Attribution International License (CC BY 4.0).</p><p>http://creativecommons.org/licenses/by/4.0/</p><p><img src="//html.hanspub.org/file/51-1572265x8_hanspub.png" /> <img src="//html.hanspub.org/file/51-1572265x9_hanspub.png" /></p></sec><sec id="s5"><title>1. 引言</title><p>随着现代交通工具的发展以及人口老龄化问题日趋严重，骨折的发生率也随之水涨船高。暴力创伤及老龄骨质疏松造成的骨丢失和结构损伤会导致骨骼脆弱，表现为骨量低、骨几何形状变化、微结构改变及材料性能缺陷 [<xref ref-type="bibr" rid="hanspub.42751-ref1">1</xref>]。Ensrud K. E. [<xref ref-type="bibr" rid="hanspub.42751-ref2">2</xref>] 在一项流行病学研究中表明美国每年骨折的病例超过200万，占全年医疗保健费用近200亿美元。其中约有10%的患者后期出现骨折不愈合或者延迟愈合的情况，这不仅对患者及家属心理造成负担，二次手术带来的经济问题也不容小觑，更有甚者严重影响患者生存质量。</p></sec><sec id="s6"><title>2. PDGF结构及机制</title><sec id="s6_1"><title>2.1. PDGF结构</title><p>血小板来源的生长因子(PDGF)是成纤维细胞、平滑肌细胞和其他细胞的主要有丝分裂原。最初，PDGF被确定为全血清的一种成分，在无细胞血浆来源的血清中是不存在的，随后从人类血小板中纯化出PDGF。近二十年来，已知的PDGF多肽只有两种，即PDGF-a和PDGF-b，这与VEGF家族形成了对比，在过去的几年中，VEGF家族扩大到5个成员，即VEGF-a，VEGF-b，VEGF-c，VEGF-d和胎盘生长因子(PlGF)，但最近发现了PDGF-c和PDGF-d这两个新的PDGF，形成了一个单独的PDGF亚家族 [<xref ref-type="bibr" rid="hanspub.42751-ref3">3</xref>] [<xref ref-type="bibr" rid="hanspub.42751-ref4">4</xref>] [<xref ref-type="bibr" rid="hanspub.42751-ref5">5</xref>]。PDGF可以与其他生物因子协同作用，共同刺激骨组织再生 [<xref ref-type="bibr" rid="hanspub.42751-ref6">6</xref>]。</p></sec><sec id="s6_2"><title>2.2. 作用机制</title><p>PDGFR/PDGF系统包括2个受体(PDGFRa和PDGFRb)和4个配体(PDGF-a、B、C和D)，这些受体是具有胞外配体结合结构域的质膜跨越蛋白，其中包括5个类免疫球蛋白结构域、一个单一跨膜结构域、一个调控近膜结构域和一个胞内催化结构域 [<xref ref-type="bibr" rid="hanspub.42751-ref7">7</xref>]。PDGF异构体通过结合并激活两个结构相关的蛋白酪氨酸激酶受体(a受体和b受体)来发挥其细胞效应。PDGF受体的激活不仅能刺激细胞生长，还能改变细胞形态和活动性。两种PDGF受体在细胞中可以单独表达，也可以一起表达。另一方面，血小板衍生的生长因子也抑制细胞间的间隙连接通讯，发挥抗凋亡作用 [<xref ref-type="bibr" rid="hanspub.42751-ref8">8</xref>]。</p></sec></sec><sec id="s7"><title>3. PDGF促进骨折愈合机制</title><sec id="s7_1"><title>3.1. PDGF提高骨折区域骨传导能力</title><p>血小板来源的生长因子(PDGF)已被报道可以刺激骨折愈合。多项研究表明，PDGF在激活成骨细胞或骨祖细胞中发挥关键作用，但其机制尚不清楚 [<xref ref-type="bibr" rid="hanspub.42751-ref9">9</xref>]。骨折的修复始于骨折区域的出血，伴随炎症反应，膜内成骨及软骨成骨，趋化不同生长因子，促进骨折区各种细胞增殖。范志勇 [<xref ref-type="bibr" rid="hanspub.42751-ref10">10</xref>] 等人通过培养SD大鼠，观察富含血小板血浆(PRP)对其颅骨成骨细胞增殖的影响，表明了骨折修复过程中PDGF趋化有成骨能力的细胞向骨折区转移，大大提高骨传导力，从而更有效提高骨折的修复和新生。</p></sec><sec id="s7_2"><title>3.2. PDGF促进骨折区血管再生</title><p>血管再生主要通过内皮细胞形成毛细血管从现有血管向骨折断端延伸而成。血管的再生与重建是骨折愈合中骨形成和修复的基本过程之一，前期的血管再生与重建对骨折愈合至关重要。血管生成反应通过传递免疫细胞，清除碎片，并为组织再生提供营养 [<xref ref-type="bibr" rid="hanspub.42751-ref11">11</xref>]。最近一项研究表明，一种特殊的血管亚型，CD31和内核蛋白(CD31hiEmcnhi)，对血管生成和成骨具有积极作用。Xie H [<xref ref-type="bibr" rid="hanspub.42751-ref12">12</xref>] 等人报道了破骨前细胞分泌的血小板衍生生长因子-bb (PDGF-BB)在骨建模和骨重塑过程中诱导CD31hiEmcnhi血管的形成，从而促进小鼠骨形成。CD31hiEmcnhi血管是一种特殊的血管亚型，可以促进血管生成和成骨。然而，在连接成骨过程中，血管生成的细胞和分子调控仍然是不清楚的。局部充足的血供通过输送营养物质、氧气、矿物质和代谢废物对维持成骨基质的合成和矿化极其重要。皮质骨被毛细血管包围，毛细血管与连接骨膜和骨内膜的纵向哈弗氏管和横向沃克曼管网络相互作用。在与生长相关的建模过程中，内皮细胞侵入生长板区域的软骨，形成营养供应的血管通道，并作为新骨形成的支架 [<xref ref-type="bibr" rid="hanspub.42751-ref13">13</xref>]。</p></sec><sec id="s7_3"><title>3.3. PDGF调节骨细胞代谢</title><p>PDGF在成骨细胞或成骨细胞激活中起着至关重要的作用，尽管其潜在机制尚不清楚。Wu Y等人 [<xref ref-type="bibr" rid="hanspub.42751-ref9">9</xref>] 通过PDGF和G蛋白偶联受体激酶相互作用蛋白1 (GIT1)在PDGF刺激和GIT1小干扰RNA转染下，对大鼠颅骨分离成骨细胞增殖和凋亡的影响的研究。表明了PDGF能迅速刺激成骨细胞GTI1的表达，增加成骨细胞的增殖，抑制细胞凋亡。多项研究发现研究发现，G蛋白偶联受体激酶相互作用-1 (GIT1)被PDGF激活，并被描述为骨代谢的重要因素。其他相关研究也表明PDGF能够刺激成骨细胞和软骨细胞的DNA复制和蛋白质合成，促进G0/G1期阻滞的成骨细胞进入S期，诱导成骨细胞的细胞分裂和增殖 [<xref ref-type="bibr" rid="hanspub.42751-ref14">14</xref>]。</p></sec><sec id="s7_4"><title>3.4. PDGF与其他生长因子共同作用促进骨折愈合</title><p>骨形态发生蛋(bonemorphogenetic protein-2, BMP-2)是目前最肯定的具有诱导成骨作用的生长因子，在修复骨缺损及愈合中效果显著 [<xref ref-type="bibr" rid="hanspub.42751-ref15">15</xref>]。BMP是转化生长因子β超家族中的一组多功能细胞因子，应彬彬等人 [<xref ref-type="bibr" rid="hanspub.42751-ref16">16</xref>] 也通过对兔下颌骨牵张成骨实验动物模型研究表明BMP可能在牵张成骨过程的早期发挥重要作用，使未分化间充质细胞向骨细胞系分化，促进骨折修复。Wang X等人 [<xref ref-type="bibr" rid="hanspub.42751-ref17">17</xref>] 研究表明在体外，骨膜衍生祖细胞对PDGF有高度的反应，然而，PDGF通过抑制典型的BMP2/Smad通路和下游靶基因的表达而阻断BMP2诱导的成骨。故而BMP2和PDGF在骨折愈合的不同阶段可能起着不同的作用。由PDGF促进的骨膜祖细胞的募集和增殖，可能是BMP2诱导的后续成骨分化所必需的。PDGF调节BMP2诱导共同促进骨膜祖细胞成骨作用。骨愈合还依赖于成骨细胞分泌的血管内皮生长因子(VEGF)的促血管生成作用。Rui Z E等人 [<xref ref-type="bibr" rid="hanspub.42751-ref18">18</xref>] 研究表明了PDGF刺激后成骨细胞VEGFmRNA表达均显著增加，VEGF是骨折愈合的主要调节因子。促进血管生成促进骨愈合，而VEGF通过刺激内皮细胞分泌多种骨代谢因子，包括内皮素-I和胰岛素样生长因子-I间接诱导成骨细胞增殖、迁移和分化)。血管化通过VEGF促进软骨吸收、骨化和骨膜下骨形成。研究了胰岛素样生长因子(IGF-I)和/或血小板衍生生长因子(PDGF)对雄性大鼠成骨细胞相关标记物基因表达的个体和联合作用，IGF-I比PDGF在旧骨中更好地刺激成骨细胞标记表达，两者协同作用影响成骨细胞标记物的表达，在骨折愈合过程中发挥至关重要的作用。</p></sec></sec><sec id="s8"><title>4. PDGF促进骨折愈合的临床与实验研究</title><sec id="s8_1"><title>4.1. PDGF促进骨折愈合的基础研究</title><p>陈建廷等人 [<xref ref-type="bibr" rid="hanspub.42751-ref19">19</xref>] 从胎鼠颅骨分离、培养成骨细胞，观察PDGF对成骨细胞DNA合成及细胞周期的影响；通过流式细胞仪以及透射电镜观察发现实验组中PDGF对培养24小时的成骨细胞S期的DNA含量较对照组明显增高(17.7%)，实验组细胞内线粒体更丰富，粗面内质网增多从而证明了PDGF通过刺激DNA合成，促进成骨细胞的分裂、增殖。ANDREW，J.等 [<xref ref-type="bibr" rid="hanspub.42751-ref20">20</xref>] 研究了16例伤后不同时间正常骨折愈合的活检材料，采用免疫组织化学方法对标本中PDGF进行了检测，并对PDGFA和B链进行了原位杂交，证明了骨折愈合过程中，PDGFA链基因在较长时间内被成骨细胞、软骨细胞、破骨细胞中的内皮细胞和Mese~hchymai细胞等多中细胞中表达，从而在骨折愈合过程中发挥重要作用。Tanaka，H. [<xref ref-type="bibr" rid="hanspub.42751-ref21">21</xref>] 等人建立成年大鼠骨髓模型后，PDGF和/或IGF-I在骨髓消融后5天直接注入右侧股骨，用点印迹分析方法分析了相对m RNA含量。在未受伤的股骨中，成骨细胞标记物的mRNA水平很低(数据未显示)，但骨髓消融显著增强了活性，调节骨细胞代谢。李菊根等人 [<xref ref-type="bibr" rid="hanspub.42751-ref22">22</xref>] 通过酶消化分段收集法分离培养出人成骨细胞，利用MTT法检测成骨细胞产生甲臢结晶的含量，观察成骨细胞的增殖能力和生长情况，证明了PDFG-BB可以刺激成骨细胞的增殖，且与IGF-Ⅱ联合应用对成骨细胞的增殖有协同作用。Mitlak BH [<xref ref-type="bibr" rid="hanspub.42751-ref23">23</xref>] 通过系统地对严重缺乏雌激素的大鼠静脉注射PDGF，组织形态学分析表明，PDGF治疗可增加成骨细胞数量和成骨细胞周长，而破骨细胞估计值无一致变化。</p></sec><sec id="s8_2"><title>4.2. PDGF促进骨折愈合的临床试验</title><p>关于PDGF对骨折患者的愈合过程影响的研究相对较少，且质量较低。马庆宏等 [<xref ref-type="bibr" rid="hanspub.42751-ref24">24</xref>] 选择单纯四肢长管状骨骨折患者25例以及合并脑外伤四肢长管状骨骨折患者25例分别于伤后3天和10天抽取静脉血ELISA测定血清中血管内皮生长因子及血小板衍生生长因子含量。证明了血管内皮生长因子及血小板衍生生长因子在骨折后持续升高，在骨折愈合中发挥重要作用。Graham S等人 [<xref ref-type="bibr" rid="hanspub.42751-ref25">25</xref>] 利用医学搜索引擎MEDLINE/OVID (1950年至2008年3月)和EMBASE (1980年至2008年3月)数据库系统地收集体外和体内证据表明，PDGF-BB以及在较小程度上PDGF-AA可能在治疗人类骨质疏松症和骨愈合方面有潜在的治疗用途。迄今为止，PDGF促进骨折愈合仍缺乏大样本、高质量的临床试验。</p></sec></sec><sec id="s9"><title>5. PDGF临床应用前景以及遇到的问题</title><p>PDGF对于临床上用于治疗骨折患者仍有许多问题待解决。由于单纯应用PDGF在体内半衰期短，无法长时间保持有效的活性，而骨折的治疗需大剂量、长期持续注射，这大大限制了PDGF的临床应用。PDGF通过促进骨折断端的血管再生，调节成骨细胞和破骨细胞的代谢等方面加速骨折愈合。但目前PDGF促进骨折愈合仍缺乏可信的临床证据，仍需要进一步的多中心、大样本的临床试验证实PDGF促进骨折愈合的临床效果与作用机制。目前，临床上仍有5%~10%的骨折患者存在骨愈合不良或骨不连，应用安全有效、非手术方式促进骨折愈合、治疗骨不连是骨科研究的重要课题之一。局部应用PDGF制剂具有安全高效、方便直接、不良反应小等优点，关于PDGF的进一步研究和应用，可能会为骨不连的治疗提供一个可行的、无创的解决方案。</p></sec><sec id="s10"><title>文章引用</title><p>王亚楠,曹志强. PDGF促进骨折愈合的研究进展Research Progress of PDGF in Promoting Fracture Healing[J]. 临床医学进展, 2021, 11(05): 2381-2386. https://doi.org/10.12677/ACM.2021.115342</p></sec><sec id="s11"><title>参考文献</title></sec></body><back><ref-list><title>References</title><ref id="hanspub.42751-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Friedman, S.M. and Mendelson, D.A. (2014) Epidemiology of Fragility Fractures. Clinics in Geriatric Medicine, 30, 175-181. &lt;br&gt;https://doi.org/10.1016/j.cger.2014.01.001</mixed-citation></ref><ref id="hanspub.42751-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Ensrud, K.E. (2013) Epidemiology of Fracture Risk with Advancing Age. Journals of Gerontology, 68, 1236-1242.  
&lt;br&gt;https://doi.org/10.1093/gerona/glt092</mixed-citation></ref><ref id="hanspub.42751-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Reigstad, L.J., Varhaug, J.E. and Lillehaug, J.R. (2010) Structural and Functional Specificities of PDGF-C and PDGF-D, the Novel Members of the Platelet-Derived Growth Factors Family. FEBS Journal, 272, 5723-5741.  
&lt;br&gt;https://doi.org/10.1111/j.1742-4658.2005.04989.x</mixed-citation></ref><ref id="hanspub.42751-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Betsholtz, C., Karlsson, L. and Lindahl, P. (2001) Developmental Roles of Platelet-Derived Growth Factors. Bioessays, 23, 494-507. &lt;br&gt;https://doi.org/10.1002/bies.1069</mixed-citation></ref><ref id="hanspub.42751-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Westermark, B. (1995) Platelet-Derived Growth Factor. A Growth Factor of Great Physiopathological Importance. Lakartidningen, 92, 2397-2401.</mixed-citation></ref><ref id="hanspub.42751-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">韩爽, 杨学文. 牵张成骨中生长因子的研究进展[J]. 口腔医学研究, 2014, 30(4): 378-380.</mixed-citation></ref><ref id="hanspub.42751-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Jones, A.V. and Cross, N.C.P. (2004) Oncogenic Protein Tyrosine Kinases: Oncogenic Derivatives of Platelet-Derived Growth Factor Receptors. Cellular and Molecular Life Sciences: CMLS, 61, 2912-2923.  
&lt;br&gt;https://doi.org/10.1007/s00018-004-4272-z</mixed-citation></ref><ref id="hanspub.42751-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Heldin, C.H. and Westermark, B. (1999) Mechanism of Action and in Vivo Role of Platelet-Derived Growth Factor. Physiological Reviews, 79, 1283-1316. &lt;br&gt;https://doi.org/10.1152/physrev.1999.79.4.1283</mixed-citation></ref><ref id="hanspub.42751-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Wu, Y., Zhang, Y., Yin, Q., et al. (2014) Platelet-Derived Growth Factor Promotes Osteoblast Proliferation by Activating G-Protein-Coupled Receptor Kinase Interactor-1. Molecular Medicine Reports, 10, 1349-1354.  
&lt;br&gt;https://doi.org/10.3892/mmr.2014.2374</mixed-citation></ref><ref id="hanspub.42751-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Fan, Z.Y., Zhang, Y.Z., Ma, W., et al. (2007) Effect of Platelet-Rich Plasma on the Proliferation and Differentiation of Cranial Osteoblasts from Neonate Rats. Journal of Clinical Rehabilitative Tissue Engineering Research.</mixed-citation></ref><ref id="hanspub.42751-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Bodnar, R.J. (2015) Chemokine Regulation of Angiogenesis during Wound Healing. Advances in Wound Care, 4, 641-650. &lt;br&gt;https://doi.org/10.1089/wound.2014.0594</mixed-citation></ref><ref id="hanspub.42751-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Xie, H., Cui, Z., et al. (2014) PDGF-BB Secreted by Preosteoclasts Induces Angiogenesis during Coupling with Osteogenesis. Nature Medicine, 20, 1270-1278. &lt;br&gt;https://doi.org/10.1038/nm.3668</mixed-citation></ref><ref id="hanspub.42751-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Chim, S.M., Tickner, J., Chow, S.T., et al. (2013) Angiogenic Factors in Bone Local Environment. Cytokine &amp; Growth Factor Reviews, 24, 297-310. &lt;br&gt;https://doi.org/10.1016/j.cytogfr.2013.03.008</mixed-citation></ref><ref id="hanspub.42751-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Zhao, G., Zhang, L., Liu, Y., et al. (2016) Effects of Platelet-Derived Growth Factor on Chondrocyte Proliferation, Migration and Apoptosis via Regulation of GIT1 Expression. Molecular Medicine Reports, 14, 897-903.  
&lt;br&gt;https://doi.org/10.3892/mmr.2016.5291</mixed-citation></ref><ref id="hanspub.42751-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">廖庆庆, 曾剑玉. 神经生长因子对骨髓基质细胞成骨作用影响的研究进展[J]. 现代口腔医学杂志, 2013(4): 231-235.</mixed-citation></ref><ref id="hanspub.42751-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">应彬彬, 胡静, 邹淑娟, 等. BMP和PDGF在兔下颌牵张后新骨组织中的时空表达[J]. 现代口腔医学杂志, 2003, 17(5): 392-394.</mixed-citation></ref><ref id="hanspub.42751-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Wang, X., Matthews, B.G., Yu, J., et al. (2019) PDGF Modulates BMP2-Induced Osteogenesis in Periosteal Progenitor Cells. JBMR Plus, 3, e10127. &lt;br&gt;https://doi.org/10.1002/jbm4.10127</mixed-citation></ref><ref id="hanspub.42751-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Rui, Z.E., Xiang, L.I., Fan, J., et al. (2012) GIT1Y321 Phosphorylation Is Required for ERK1/2- and PDGF-Dependent VEGF Secretion from Osteoblasts to Promote Angiogenesis and Bone Healing. International Journal of Molecular Medicine, 30, 819-825. &lt;br&gt;https://doi.org/10.3892/ijmm.2012.1058</mixed-citation></ref><ref id="hanspub.42751-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">陈建庭, 李菊根, 金大地. 血小板衍生生长因子促进成骨细胞DNA合成的实验研究[J]. 中华外科杂志, 1999, 37(7): 409-411.</mixed-citation></ref><ref id="hanspub.42751-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Andrew, J. (1995) Platelet-Derived Growth Factor Expression in Normally Healing Human Fractures. Bone, 16, 455-460.  
&lt;br&gt;https://doi.org/10.1016/8756-3282(95)90191-4</mixed-citation></ref><ref id="hanspub.42751-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Tanaka, H. (2002) Effect of IGF-I and PDGF Administered in Vivo on the Expression of Osteoblast-Related Genes in Old Rats. Journal of Endocrinology, 174, 63-70. &lt;br&gt;https://doi.org/10.1677/joe.0.1740063</mixed-citation></ref><ref id="hanspub.42751-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">李菊根, 陈建庭, 金大地. 血小板源性生长因子对成骨细胞作用影响的实验研究[J]. 现代医院, 2008(4): 9-10.</mixed-citation></ref><ref id="hanspub.42751-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Mitlak, B.H., Finkelman, R.D., Hill, E.L., et al. (1996) The Effect of Systemically Administered PDGF-BB on the Rodent Skeleton. Journal of Bone &amp; Mineral Research, 11, 238-247.</mixed-citation></ref><ref id="hanspub.42751-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">马庆宏, 邱昊, 周信, 等. VEGF、PDGF在合并脑外伤肢体骨折患者血清中含量分析的临床研究[J]. 齐齐哈尔医学院学报, 2013, 34(21): 3155-3156.</mixed-citation></ref><ref id="hanspub.42751-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Graham, S., Leonidou, A., Lester, M., et al. (2009) Investigating the Role of PDGF as a Potential Drug Therapy in Bone Formation and Fracture Healing. Expert Opinion on Investigational Drugs, 18, 1633-1654.  
&lt;br&gt;https://doi.org/10.1517/13543780903241607</mixed-citation></ref></ref-list></back></article>